Navigation Links
CareFusion Moves First Quarter Earnings Announcement to November 5
Date:11/3/2009

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® for infection prevention and MedMined(TM) services for infection surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.

SOURCE CareFusion Corporation


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. CareFusion Shipping Ventilators to CDC for National Emergency Preparedness
2. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
3. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
4. GHX Health ConneXion(TM) Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption
5. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
6. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
7. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
8. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
9. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
10. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
11. Corgenix to Host Conference Call to Discuss Fiscal 2010 First Quarter Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...lif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nas...int-of-carebloodanalysissystems,announcedtodaythat...lpresentatthe21stAnnualPiperJaffrayHealthCareConfe...ferencewillbeheldattheNewYorkPalaceHotelinNewYorkC...facturesandmarketsportablebloodanalysissystemsforu...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasdaq: N...uctsforminimallydisruptivesurgicaltreatmentsforthe...nMonday,November30,2009,at5:30p.m.ET/2:30p.m.PT.Th...eimbursementfortheCompany,sproductsandwillincludec...swersession.Thedial-innumbersare1-877-407-4018ford...
(Date:11/25/2009)...25/PRNewswire/--Reportlinker.comannouncesthatanewm..., IntranasalDrugDelivery-USMarketTrends&Analy...al-Drug-Delivery---US-Market-Trends--Analysis.html...inganexpansionoftherapeuticapplicationsfromthedeli...ryofsystemictherapeuticdrugs.Thefutureofthetechnol...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 1Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 3Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 4Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 1Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 2Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 3Household Insecticides May Be Linked to Autoimmune Diseases 59735 1Household Insecticides May Be Linked to Autoimmune Diseases 59735 2Household Insecticides May Be Linked to Autoimmune Diseases 59735 3
...urnal Blood found 92 percent reduction in ... Conn., Aug. 20 Patients with a rare,blood disord...n the,incidence of life-threatening blood clots (t...culizumab), according to an analysis of clinical s...rnal of the American Society of,Hematology. Solir...
...1 Genaera,Corporation (Nasdaq: GENR ) today repo...initiated a multi-dose, Phase 2a clinical trial wi...ukin-9 (IL-9) in adults with,mild, persistent asth...is,designed to evaluate the safety and tolerabilit... the second Phase 2a study currently underway with...
Other Medicine Technology:PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 2Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 3Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program 4
(Date:11/26/2009)...o more letters from the North Pole, Textsanta.net ...s from Santa , North Pole...al efficiencies at the North Pole Santa Claus has ... over the globe informed of his Christmas progress...earch department have identified a large and growi...
(Date:11/25/2009)...PRNewswire-USNewswire/--Whenmostpeopleheartheacron...lsogivepatientsthehelptheyneed.TMJstandsfortheTemp...contacts/connectswithyourskull(temporalbone). ,...narepainwithchewing,clickingorpoppingofthejaw.Butm...ding:headaches,fatigue,sleepdisturbances,irritabil...
(Date:11/25/2009)...v.25/PRNewswire/--Thanksgivingmealswillbedelivered...ngBeachareathankstoFaithInAction/VolunteerActionfo...divisionofSCANHealthPlan.Formorethan17yearstheseor...erwarmThanksgivingmealstoseniorsinneedinLongBeach,...roundingcities. ,, "Ourwarmholidaymealsaredeliv...
(Date:11/25/2009)...sticular cancer who were treated with cisplatin-ba...luding neurological side effects and Raynaud-like ...otherapy, according to a new study published onlin...er Institute . , Marianne Brydy, M.D., of the De...l, in Bergen, Norway, and colleagues conducted a c...
(Date:11/25/2009)...fight rheumatoid arthritis, could help newly diagn...Y, Nov. 25 (HealthDay News) -- A drug commonly use...rthritis now also shows some promise in helping pa...The drug, rituximab (Rituxan), helped patients kee... the disease had destroyed some of their pancreati...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...ts at the Ohio State University have discovered a ...ainst the invasion of the HIV/AIDS virus. //It was...f injured DNA also destroy the DNA of the HIV viru...this discovery might lead to newer treatments targ...
...ts in Canada has said that choosing and eating the...erapy in lowering the cholesterol level//. Da...y of Toronto studied people who ate a diet high in... The participants, including 66 women and me...
...een proposed by the Ohio-based Cleveland Clinic, t...is summer, the services which would benefit Canadi...or medical treatment. The Cleveland clinic houses ...addition to information on health care options ava...
...ar study was conducted by the psychiatrist Dr Char... was backed by the National Institutes of Health//...fect of treating depression using drugs and psycho...onger periods, perhaps even for life, in patients ...
...epartment of New South Wales has conducted a study... serious impact on the user's physical health// . ...al health conditions. Cannabis abuse can lead to c... Wales Health Minister John Hatzistergos will open...
...ers at Yale shed new light on the mechanism of ner...a molecular "motor" protein, myosin-II, according ...Biology. As nerve cells develop or attempt to re...er to direct advance of the nerve cells and it has...
Other Medicine News:Health News:Satellite Clinic To Be Set Up in Toronto By Ohio-Based Cleveland Clinic 2Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:A New Focus For The Mechanism Of Nerve Growth 2
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: